Total Payments
$11,877
2024 Payments
$1,544
Companies
24
Transactions
404
Medicare Patients
2,980
Medicare Billing
$646,660
Payment Breakdown by Category
Food & Beverage$9,319 (78.5%)
Travel$2,464 (20.7%)
Education$93.87 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,319 | 391 | 78.5% |
| Travel and Lodging | $2,464 | 11 | 20.7% |
| Education | $93.87 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $2,157 | 94 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $1,530 | 10 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,363 | 71 | $0 (2024) |
| Lundbeck LLC | $938.76 | 44 | $0 (2024) |
| PTC Therapeutics, Inc. | $774.35 | 2 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $655.48 | 57 | $0 (2022) |
| Neuronetics, Inc. | $495.45 | 5 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $460.82 | 9 | $0 (2023) |
| ABBVIE INC. | $437.88 | 15 | $0 (2024) |
| Allergan, Inc. | $435.95 | 20 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,544 | 52 | Otsuka America Pharmaceutical, Inc. ($403.57) |
| 2023 | $1,667 | 64 | Teva Pharmaceuticals USA, Inc. ($289.53) |
| 2022 | $1,343 | 68 | Otsuka America Pharmaceutical, Inc. ($354.79) |
| 2021 | $1,149 | 57 | Takeda Pharmaceuticals U.S.A., Inc. ($247.43) |
| 2020 | $931.55 | 29 | Neuronetics, Inc. ($495.45) |
| 2019 | $2,722 | 56 | JAZZ PHARMACEUTICALS INC. ($775.91) |
| 2018 | $1,819 | 44 | Jazz Pharmaceuticals Inc. ($733.60) |
| 2017 | $701.65 | 34 | Gilead Sciences Inc ($249.99) |
All Payment Transactions
404 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.42 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $145.96 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.04 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $8.37 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $108.06 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $3.39 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.65 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: PSYCHIATRY | ||||||
| 08/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $9.99 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $33.30 | General |
| Category: PSYCHIATRY | ||||||
| 07/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 666 | 1,791 | $324,875 | $125,542 |
| 2022 | 7 | 738 | 2,431 | $414,200 | $157,387 |
| 2021 | 7 | 739 | 2,913 | $491,475 | $189,084 |
| 2020 | 8 | 837 | 3,004 | $483,450 | $174,648 |
Total Patients
2,980
Total Services
10,139
Medicare Billing
$646,660
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 229 | 766 | $115,000 | $53,212 | 46.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 212 | 641 | $112,175 | $36,773 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 346 | $86,500 | $30,383 | 35.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 21 | 21 | $5,250 | $3,324 | 63.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $5,950 | $1,850 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 280 | 1,202 | $180,300 | $81,333 | 45.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 275 | 1,021 | $178,675 | $53,005 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 84 | $21,000 | $9,300 | 44.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 41 | 41 | $10,250 | $6,152 | 60.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 42 | 45 | $15,750 | $5,100 | 32.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 21 | $5,250 | $1,261 | 24.0% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 12 | 17 | $2,975 | $1,235 | 41.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 298 | 1,377 | $206,550 | $97,167 | 47.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 298 | 1,378 | $241,150 | $74,552 | 30.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 40 | 40 | $10,000 | $6,359 | 63.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 50 | 54 | $18,900 | $6,160 | 32.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 20 | $5,000 | $2,048 | 41.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 29 | $7,250 | $1,736 | 24.0% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 15 | 15 | $2,625 | $1,063 | 40.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 303 | 1,334 | $189,250 | $80,228 | 42.4% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 305 | 1,431 | $249,150 | $77,899 | 31.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 34 | 38 | $13,300 | $4,539 | 34.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 38 | 38 | $9,500 | $4,504 | 47.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 15 | $3,750 | $2,585 | 68.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 28 | $7,000 | $2,538 | 36.3% |
About Dr. Robert Imani, M.D
Dr. Robert Imani, M.D is a Child & Adolescent Psychiatry healthcare provider based in Lancaster, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639374747.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Imani, M.D has received a total of $11,877 in payments from pharmaceutical and medical device companies, with $1,544 received in 2024. These payments were reported across 404 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($9,319).
As a Medicare-enrolled provider, Imani has provided services to 2,980 Medicare beneficiaries, totaling 10,139 services with total Medicare billing of $646,660. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Other Specialties Psychiatry
- Location Lancaster, CA
- Active Since 06/19/2007
- Last Updated 01/08/2014
- Taxonomy Code 2084P0804X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639374747
Products in Payments
- REXULTI (Drug) $2,634
- TRINTELLIX (Drug) $852.75
- VRAYLAR (Drug) $663.26
- LATUDA (Drug) $655.48
- CAPLYTA (Drug) $527.78
- Trintellix (Drug) $508.47
- NEUROSTAR TMS THERAPY (Device) $495.45
- SPRAVATO (Drug) $460.82
- Epclusa (Drug) $374.99
- BRINTELLIX (Drug) $257.78
- Austedo XR (Drug) $217.89
- ABILIFY MAINTENA (Drug) $214.28
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $189.86
- ARISTADA (Drug) $176.30
- LYBALVI (Drug) $167.22
- Azstarys (Drug) $159.78
- Auvelity (Drug) $156.03
- BOTOX COSMETIC (Biological) $127.66
- Dayvigo (Drug) $114.99
- QELBREE (Drug) $89.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Child & Adolescent Psychiatry Doctors in Lancaster
Santoshkumar Mathapati, M.d, M.D
Child & Adolescent Psychiatry — Payments: $3,104
Child & Adolescent Psychiatry $3,104
Nathaniel Johns, Md, MD
Child & Adolescent Psychiatry — Payments: $2,589
Child & Adolescent Psychiatry $2,589
Dr. Matthew Louie, M.d, M.D
Child & Adolescent Psychiatry — Payments: $1,288
Child & Adolescent Psychiatry $1,288
Ms. Tasneem Ali, Md, MD
Child & Adolescent Psychiatry — Payments: $629.17
Child & Adolescent Psychiatry $629.17
Olaniyi Oluleye, Md, MD
Child & Adolescent Psychiatry — Payments: $489.62
Child & Adolescent Psychiatry $489.62
Thomas Foley, M.d, M.D
Child & Adolescent Psychiatry — Payments: $407.31
Child & Adolescent Psychiatry $407.31